Ischemin sodium salt (10 mg)

64983

CBP inhibitor; cell permeable

357.36

5-[(1E)-2-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-2,4-dimethylbenzenesulfonic acid sodium salt

CBP bromodomain inhibitor. Inhibits p53 interaction with CBP and decreases p53 transcriptional activity. Protects against Doxorubicin-induced apoptosis in cardiomyocytes in vitro. Cell permeable.

≥99% (HPLC)

Soluble to 100 mM in water and to 100 mM in DMSO

CC1=CC(/N=N/C2=C(C)C=C(C)C(S(=O)(O[Na])=O)=C2)=C(N)C=C1O

C₁₅H₁₆N₃O₄SNa